期刊文献+

对1例进行性肌阵挛癫痫患者的药物监测 被引量:1

Medication monitoring on a patient with progressive myoclonic epilepsy
下载PDF
导出
摘要 1例20a女性患者因进行性肌阵挛癫痫入院治疗。第1天给予口服丙戊酸钠缓释片0.5g,每日2次,氯硝西泮片1mg,每日3次。第2天患者出现了一次强直发作。针对智能降低,对症给予静脉点滴奥拉西坦注射液4g,每日1次,用药8d;由于患者拒绝注射给药,改为口服奥拉西坦0.8g,每日2次。第6天,家属诉患者月经不调,给予口服结合雌激素片1.25mg,每日1次,共使用21d。服用结合雌激素片第11天后加用口服安宫黄体酮片10mg,每日1次,共使用10d,服药4d后,月经结束。第13天和第16天患者均出现非癫痫性心因发作,给予吸氧、静脉注射安定15mg对症处理,症状改善。第17天患者要求出院。 A 20-year-old female patient was hospitalized for progressive myoclonic epilepsy.On day 1,the patient was orally treated with sodium valproate sustained-release tablets 0.5 g twice daily,clonazepam tablets 1 mg three times a day.On day 2,the patient developed tonic seizures with intelligence obstacle.The patient was intravenously treated with oxiracetam 4 g once daily for 8 days.Eight days later,the patient was orally treated with oxiracetam 0.8 g twice daily for her refusing the intravenous administration.On day 6,the patient complained of irregular menstruation,and conjugated estrogen tablets 1.25 mg once daily was orally given for 21 days.Eleven days after the medication of conjugated estrogen tablets,medroxyprogesterone acetate tablets 10 mg once daily was added for 10 days.Four days later,her menstruation stopped.On day 13 and on day 16,the patient suffered from psychogenic non-epileptic seizures,oxygen inhalation therapy and diazepam 15 mg by intravenous injection were used,and the symptoms of the patient improved.On day 17,the patient discharged from hospital.
出处 《中国药物应用与监测》 CAS 2010年第2期124-126,共3页 Chinese Journal of Drug Application and Monitoring
关键词 进行性肌阵挛 癫痫 药物监测 Progressive myoclonus Epilepsy Drug monitoring
  • 相关文献

参考文献6

二级参考文献52

  • 1Joffe H. Reproductive biology and psychotropic treatments in premenopausal women with bipolar disorder. J Clin Psychiatry, 2007, 68(Suppl 9) : 10-15.
  • 2Stowe ZN. The use of mood stabilizes during breasffeeding. J Clin Psychiatry, 2007 , 68 ( Suppl 9 ) : 22-28.
  • 3Viguera AC, Koukopoulos A, Muzina DJ, et al. Teratogenicity and anticonvulsants : lessons from neurology to psychiatry. J Clin Psychiatry, 2007, 68(Suppl 9): 29-33.
  • 4Canadian Psychiatric Association. Clinical Practice Guidelines Management of Anxiatr Disorders 2 Principles of diagnosis and management of anxiety disorder. Can J Psychiatry, 2006, 51(Suppl 2) : 9-22.
  • 5Menegola E, Di Renzo F, Broccia ML, et al. Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res C Embryo Today, 2006, 78(4) : 345-353.
  • 6Rodriguez-Pinilla E, Mejias C, Prieto-Merino D, et al. Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a ease-control study in Spain. Drug Saf, 2008, 31 (6): 537-543.
  • 7Bonello B, Ghez O, Fraisse A. Atresia of the aortic arch, with a collateral artery from the right subclavian artery supplying the descending aorta. Cardiol Young, 2008, 18 (1) : 105-107.
  • 8Rodriguez-Vazquez M, Carrascosa-Romero MC, Pardal- Fernandez JM , et al. Congenital gingival hyperplasia in a neonate with foetal valproate syndrome. Neuropediatrics, 2007, 38(5) : 251-252.
  • 9Diav-Citrin O, Shechtman S, outcome after in utero exposure Bar-O2 B, et al. Pregnancy to valproate : evidence of dose relationship in teratogenic effect. CNS Drugs, 2008, 22 (4) : 325-334.
  • 10Eadie MJ, Vajda FJ. Should valproate be taken during pregnancy? Ther Clin Risk Manag, 2005 , 1 ( 1 ) : 21 -26.

共引文献26

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部